Daisuke Usui
Net worth: 213 932 $ as of 2026-05-30
Net worth: 213 932 $ as of 2026-05-30
Daisuke Usui currently works at ReproCELL, Inc., as Chief Operating Officer & Director from 2020, RC Partners, Inc., as Director from 2016, ReproCELL Europe Ltd., as Director from 2016, and MAGiQ Therapeutics KK, as Director from 2019.
Mr. Usui also formerly worked at Reinnervate Ltd., as Chief Executive Officer.
Mr. Usui received his undergraduate degree from the University of Tsukuba.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPROCELL INC. 0.28% | 2025-03-30 | 264,000 ( 0.28% ) | 213 932 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| REPROCELL INCORPORATED | Chief Operating Officer | 2020-11-10 |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Director/Board Member | 2016-05-31 |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Director/Board Member | 2016-06-30 |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Director/Board Member | 2019-11-30 |
| Companies | Position | End |
|---|---|---|
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of Tsukuba
University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Health Technology |
ReproCELL, Inc.
ReproCELL, Inc. Medical SpecialtiesHealth Technology Engages in the reagents for ES/iPS and stem cell-derived functional cells | Health Technology |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Finance |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Commercial Services |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions